Everyone transitions to retirement differently. See full story.
Trump isn’t going quietly and fiscal stimulus won’t come easily, but investors have bigger things to worry about
2020 has already been a year for the record books, and by some reckoning the hardest parts are still ahead. See full story.
BioNTech and Pfizer’s COVID-19 vaccine is surprisingly effective, though experts question what effectiveness will look like in the real world
BioNTech and Pfizer Inc.’s unexpectedly efficacious COVID-19 vaccine candidate caught Wall Street and the medical community by surprise this week, yet the same experts who are thrilled by the news caution that the effectiveness of the vaccine will likely be lower in the real world. See full story.
The pandemic isn’t stopping one New York councilman from hosting a big Thanksgiving gathering — and a new survey shows he’s not alone
People are planning gatherings even as daily COVID-19 case counts keep breaking records. See full story.
These are the 14 value stocks that top-performing investment newsletters like the most
Many of the newsletter editors think value is finally reasserting its historical dominance over growth. See full story.
Also, your own fancy condo down south, retirement planning and Zoom’s path to making investors a lot of money. See full story.